CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+5.2%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$6.92B
AUM Growth
+$6.92B
(-1.7%)
Cap. Flow
-$368M
Cap. Flow
% of AUM
-5.32%
Top 10 Holdings %
Top 10 Hldgs %
73.6%
Holding
128
New
2
Increased
25
Reduced
68
Closed
5
Top Buys
| 1 |
Visa
V
|
$14.1M |
| 2 |
Citigroup
C
|
$10.4M |
| 3 |
Ecolab
ECL
|
$9.84M |
| 4 |
Home Depot
HD
|
$9.17M |
| 5 |
Amazon
AMZN
|
$9.13M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$283M |
| 2 |
Meta Platforms (Facebook)
META
|
$53.9M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$44.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$12.8M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$5.74M |
Sector Composition
| 1 | Financials | 30.75% |
| 2 | Consumer Discretionary | 19.53% |
| 3 | Communication Services | 15.03% |
| 4 | Healthcare | 13.85% |
| 5 | Materials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Gilead Sciences
GILD
$140B
| $25.2M | 0.36% |
351,908
-3,955,127
| -92% | -$283M |
|
27
Pfizer
PFE
$141B
| $19.9M | 0.29% |
549,379
| – | – |
|
28
Amgen
AMGN
$153B
| $19.3M | 0.28% |
110,716
| – | – |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $18.6M | 0.27% |
177,762
-1,257
| -0.7% | -$131K |
|
|
AGN
30
DELISTED
Allergan plc
AGN
| $15.6M | 0.22% |
95,086
| – | – |
|
31
Dynavax Technologies
DVAX
$1.18B
| $14.4M | 0.21% |
770,441
-53,384
| -6% | -$998K |
|
32
AbbVie
ABBV
$375B
| $13.9M | 0.2% |
143,271
| – | – |
|
|
SHPG
33
DELISTED
Shire pic
SHPG
| $13.5M | 0.2% |
87,322
+18,103
| +26% | +$2.81M |
|
34
Viatris
VTRS
$12.3B
| $13.4M | 0.19% |
316,045
+129,506
| +69% | +$5.48M |
|
35
Bristol-Myers Squibb
BMY
$97.1B
| $13.1M | 0.19% |
213,452
-43,579
| -17% | -$2.67M |
|
36
Biogen
BIIB
$21B
| $13.1M | 0.19% |
40,974
-8,691
| -17% | -$2.77M |
|
37
Insmed
INSM
$30.6B
| $12.2M | 0.18% |
392,007
-55,422
| -12% | -$1.73M |
|
38
Cigna
CI
$79.7B
| $11.9M | 0.17% |
58,777
| – | – |
|
|
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
| $11.5M | 0.17% |
169,700
-40,927
| -19% | -$2.78M |
|
40
HCA Healthcare
HCA
$94.9B
| $11.5M | 0.17% |
130,618
| – | – |
|
41
Merck
MRK
$213B
| $11.3M | 0.16% |
200,817
| – | – |
|
|
ESRX
42
DELISTED
Express Scripts Holding Company
ESRX
| $11.2M | 0.16% |
150,710
+36,442
| +32% | +$2.72M |
|
|
PRTK
43
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $11M | 0.16% |
614,900
-30,200
| -5% | -$541K |
|
44
Exelixis
EXEL
$10B
| $10.7M | 0.15% |
352,508
+67,920
| +24% | +$2.06M |
|
45
Eli Lilly
LLY
$659B
| $10.6M | 0.15% |
125,120
| – | – |
|
46
Edwards Lifesciences
EW
$48B
| $10.4M | 0.15% |
92,393
| – | – |
|
47
Centene
CNC
$14.5B
| $9.45M | 0.14% |
93,653
| – | – |
|
48
Boston Scientific
BSX
$159B
| $9.1M | 0.13% |
367,194
| – | – |
|
|
ALXN
49
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.05M | 0.13% |
75,704
-6,240
| -8% | -$746K |
|
50
Glaukos
GKOS
$5.4B
| $7.53M | 0.11% |
293,360
+1,935
| +0.7% | +$49.6K |
|